Zygomatic Facial Nerve Palsy

What is Zygomatic Facial Nerve Palsy?

Zygomatic facial nerve palsy refers to a partial loss of movement in the muscles that are supplied by the zygomatic branch of the facial (VII) nerve. This branch controls the muscles that raise the upper lip, smile, and create expressions around the cheeks and eyes (e.g., the orbicularis oculi). When the zygomatic branch is damaged, patients may notice a drooping corner of the mouth, weakness when smiling, and incomplete eye closure on the affected side.^[1][2]

Unlike a complete facial nerve palsy (which affects all facial muscles on one side), a zygomatic palsy is limited to the upper‑midface region. The condition can be temporary (e.g., after a viral infection) or permanent if the nerve is severely injured.

Common Causes

Several conditions can damage the zygomatic branch of the facial nerve. The most frequent causes include:

• Bell’s palsy – idiopathic inflammation of the facial nerve that often involves the zygomatic branch.
• Traumatic injury – blunt or penetrating facial trauma, such as a fracture of the zygomatic arch.
• Temporal bone fractures – fractures that extend through the facial canal.
• Surgical complications – otologic, maxillofacial, or cosmetic procedures that inadvertently injure the nerve.
• Herpes zoster (Ramsay Hunt syndrome) – reactivation of varicella‑zoster virus in the geniculate ganglion.
• Neoplastic processes – malignant or benign tumors (e.g., parotid gland tumors, schwannomas) compressing the nerve.
• Infectious inflammation – bacterial otomastoiditis or middle ear infections that spread to the facial nerve.
• Congenital anomalies – rare developmental defects that affect nerve routing.
• Systemic diseases – sarcoidosis, Lyme disease, or Guillain‑Barré syndrome with facial nerve involvement.
• Neuropathy secondary to diabetes or hypertension – microvascular ischemia can preferentially affect the zygomatic branch.

Associated Symptoms

Because the zygomatic branch mainly controls mid‑facial muscles, patients often experience the following alongside weakness:

• Inability to raise the outer part of the eyebrow.
• Asymmetrical smile or drooping of the corner of the mouth.
• Incomplete closure of the eye (lagophthalmos) leading to dryness or irritation.
• Reduced ability to blow or puff the cheeks.
• Facial numbness or tingling if adjacent sensory branches are involved.
• Pain behind the ear or in the temporomandibular joint (TMJ) region.
• Eye redness, tearing, or crusting from exposure.
• Difficulty with speech articulation that requires lip movement.

When to See a Doctor

Prompt medical evaluation is recommended if you notice any of the following:

• Sudden onset of facial weakness that does not improve within 48 hours.
• Visible drooping of the mouth or trouble closing the eye on one side.
• Severe pain around the ear, jaw, or temple.
• Accompanying fever, rash, or ear drainage – signs of infection.
• History of recent facial trauma or surgery.
• Progressive worsening of weakness over several days.
• Difficulty eating, drinking, or speaking because of facial muscle loss.

Early assessment helps differentiate reversible causes (e.g., Bell’s palsy) from those requiring urgent intervention (e.g., tumor, fracture).

Diagnosis

Diagnosis combines a careful clinical exam with targeted investigations:

Clinical evaluation

• History taking – onset, associated symptoms, recent infections, trauma, or surgeries.
• Physical exam – testing the ability to raise eyebrows, smile, puff cheeks, and close eyes; checking for asymmetry and skin folds.
• House-Brackmann grading – a 6‑point scale to quantify facial nerve function.

Imaging studies

• High‑resolution CT scan of the temporal bone – best for evaluating fractures or bony impingement.
• MRI with gadolinium – assesses soft‑tissue lesions, nerve inflammation, and tumors.
• Ultrasound – can be useful for superficial parotid or facial nerve sheath tumors.

Laboratory tests (selected cases)

• Serology for Lyme disease, syphilis, or HIV if risk factors exist.
• Inflammatory markers (ESR, CRP) for sarcoidosis or vasculitis.
• PCR testing of vesicular fluid for varicella‑zoster when Ramsay Hunt is suspected.

Electrophysiological studies

• Electroneuronography (ENoG) – measures nerve degeneration within 3‑21 days of onset.
• Electromyography (EMG) – evaluates muscle activity and helps predict recovery.

Treatment Options

Treatment is tailored to the underlying cause and the severity of the palsy.

Medical management

• Corticosteroids – early oral prednisone (e.g., 60 mg daily for 5 days then taper) improves recovery in Bell’s palsy and reduces inflammation.^[3]
• Antiviral agents (acyclovir or valacyclovir) – added if a viral cause (e.g., herpes simplex or zoster) is suspected.
• Analgesics – NSAIDs or acetaminophen for pain; neuropathic agents (gabapentin) for lingering nerve pain.
• Eye protection – lubricating eye drops, ointments, and nocturnal eye patches to prevent corneal abrasion.
• Antibiotics – indicated if a bacterial ear infection or osteomyelitis is present.
• Immunomodulatory therapy – for autoimmune conditions (e.g., steroids for sarcoidosis).

Surgical interventions

• Decompression surgery – performed within 2‑3 weeks of onset for severe traumatic or idiopathic cases with >90 % degeneration on ENoG.
• Microsurgical nerve repair or grafting – considered when the nerve is transected during trauma or surgery.
• Tumor excision – removal of compressive masses, often followed by facial reanimation procedures.
• Facial reanimation procedures – static slings, muscle transfers (e.g., temporalis muscle), or Botox to balance muscle activity when recovery is incomplete.

Rehabilitation & home care

• Facial physical therapy – daily gentle massage, stretching, and neuromuscular retraining; evidence supports improved symmetry.^[4]
• Electrical stimulation – low‑intensity devices may aid muscle tone, but should be used under professional guidance.
• Mirror exercises – patients practice smiling, pursing lips, and raising eyebrows while watching themselves.
• Nutrition – soft foods if lip weakness hampers chewing.
• Psychological support – counseling or support groups to address self‑esteem issues.

Prevention Tips

While many cases of zygomatic facial nerve palsy are unavoidable, certain measures can reduce risk:

• Wear protective helmets and face shields during high‑impact sports or when operating heavy machinery.
• Promptly treat ear infections to avoid spread to the facial nerve.
• Seek early medical care for shingles; antiviral therapy within 72 hours lowers the chance of nerve involvement.
• Maintain good control of chronic diseases (diabetes, hypertension) to lessen microvascular nerve injury.
• Inform surgeons of any prior facial nerve issues before facial or ear procedures.
• Practice safe travel habits to reduce tick exposure in Lyme‑endemic areas.

Emergency Warning Signs

Key Take‑aways

Zygomatic facial nerve palsy is a localized weakness affecting the muscles that create smiles and eye closure. Early identification of the cause—whether viral, traumatic, neoplastic, or systemic—guides appropriate treatment. Most patients improve with steroids, antivirals, and dedicated facial therapy, but persistent cases may need surgical reconstruction. Never ignore sudden facial weakness, especially when accompanied by pain, fever, or vision changes; timely professional care is essential for the best outcome.

---

References:

1. Mayo Clinic. “Facial nerve palsy.” Updated 2023. https://www.mayoclinic.org
2. National Institute of Neurological Disorders and Stroke. “Bell’s Palsy Fact Sheet.” 2022. https://www.ninds.nih.gov
3. American Academy of Otolaryngology–Head and Neck Surgery. “Clinical practice guideline: Bell’s palsy.” 2022. https://www.entnet.org
4. Cleveland Clinic. “Facial nerve rehabilitation.” 2023. https://my.clevelandclinic.org
5. World Health Organization. “Ramsay Hunt syndrome.” 2021. https://www.who.int
6. American Academy of Neurology. “Guidelines for the use of electrophysiological testing in facial nerve disorders.” 2020.